United States · Investor

Tullis Health Investors

Last cheque observed Oct 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietPrivate equityWebsite unconfirmed

SeedSeries ASeries BIn Vitro DiagnosticsMedical DevicesMedtech

Cheques on record
0%of best year0cheques in 12 months, 20 on record
Since the last cheque4038days00hrs00min00sec
Median round$12MRounds led0 of 20Sole investor1 roundsExits5 from the portfolioMostly inUnited States, 100%
Pitch Tullis Health Investors

Tullis Health Investors highlights

  1. 01

    20 rounds on record

  2. 02

    Mostly Series B and Series C: 50% of its rounds

  3. 03

    Sole investor in 1 rounds, median $122K

  4. 04

    5 exits from the portfolio

What they do

Type
Private equity (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowthPre-IPO
Sectors
In Vitro DiagnosticsMedical DevicesMedtech
Based in
North Palm Beach, United States
Cold pitches
Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.

The record

Every round we can evidence, newest first20 appearances

  1. 2015

    2 rounds

  2. Oct
    CareSyncSeries B · US$18MWith 6 others
  3. Mar
    OrthoSensorSeries C · US$19MWith 1 other
  4. 2014

    2 rounds

  5. Oct
    CareSyncSeries A · US$4.3MWith 3 others
  6. Jul
    Exagen DiagnosticsDebt · US$4.0MWith 3 others
  7. 2013

    1 round

  8. Nov
    Exagen DiagnosticsDebt · US · pehub.com$25MWith 5 others
  9. 2012

    3 rounds

  10. Sept
    Exagen DiagnosticsSeries B · US · finsmes.com$5.3MWith 4 others
  11. Jul
    EstechVenture · US$122KSole investor
  12. Feb
    Exagen DiagnosticsSeries C · US$34MWith 2 others
  13. 2011

    3 rounds

  14. Dec
    Exagen DiagnosticsSeries A · US · sec.gov$12MWith 2 others
  15. May
    Exagen DiagnosticsGrowth · US · sec.gov$5.4MWith 4 others
  16. Feb
    Exagen DiagnosticsSeries B · US$17MWith 4 others
  17. 2010

    2 rounds

  18. Dec
    EstechSeries D · US · finsmes.com$8.5MWith 3 others
  19. Mar
    BioBehavioral DiagnosticsSeries B · US · onbiovc.com$10MWith 1 other
  20. 2009

    3 rounds

  21. Oct
    Synageva BioPharmaSeries F · US · altassets.net$12MWith 4 others
  22. Oct
    Coherex MedicalSeries B · US · onbiovc.com$17MWith 2 others
  23. Apr
    Synageva BioPharmaSeries F · US · pehub.com$30MWith 1 other
  24. 2008

    1 round

  25. Apr
    AldagenSeries D · US$18MWith 3 others
  26. 2007

    1 round

  27. Sept
    AldagenSeries C · US · findarticles.com$9.0MWith 3 others
  28. 2005

    2 rounds

  29. Aug
    AdianaSeries D · US · allbusiness.com$23MWith 8 others
  30. Jun
    Exagen DiagnosticsSeries B · US · highbeam.com$7.0MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration5 named

DGDarlene G FranzeSenior Vice President and Secretary of Tullis Health Investors of Florida, LLCiForm ADV
JLJames Luther Lyman TullisChairman of Tullis Health Investors of Florida, LLCiForm ADV
JLJohn Luther TullisChief Executive Officer of Tullis Health Investors of Florida, LLCiForm ADV
LTLinda TullisMember of the Tullis Health Investors of Florida, LLCiForm ADV
NMNora MendeChief Financial OfficeriForm ADV

We also hold 9 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$59Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
Legal name
Tullis Health Investors Of Florida LLC
SEC number
CRD 288036

What they claim to have backed

From their own portfolio page (on their website)

2 of 7 we have independently watched raise

CereneElectrocoreAtecspineDocmatterExagenNewtonTrisaluslifesci

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Exits from the portfolio

Companies it backed that were later bought or listed5 in all

Coherex MedicalBought by Biosense WebsterUndisclosedNov 2015
EstechBought by AtriCure$60MDec 2013
AldagenBought by Nuo TherapeuticsUndisclosedFeb 2012
AdianaBought by Cytyc$215MFeb 2007

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Tullis Health Investors. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about Tullis Health Investors

What does Tullis Health Investors invest in?

Tullis Health Investors invests most often at Series B and Series C (50% of the rounds on record), in sectors such as In Vitro Diagnostics, Medical Devices and Medtech.

How active is Tullis Health Investors?

20 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2015.

How big are Tullis Health Investors's cheques?

The median round it joins is $12M.

Does Tullis Health Investors lead rounds?

Rarely, if at all: none of its 20 investments on record names it as the lead.

Where does Tullis Health Investors invest?

Most of the companies it backs are in the United States (100%).

Is Tullis Health Investors investing now?

No investments in the last 12 months; the latest was in Oct 2015.

Who does Tullis Health Investors invest alongside?

Most often Sun Mountain Capital (7 rounds together), Cottonwood Technology Fund (5 rounds together) and Mesa Verde Venture Partners (4 rounds together).

What kind of investor is Tullis Health Investors?

Tullis Health Investors is a private equity firm based in North Palm Beach, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it